Detalles de la búsqueda
1.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Histopathology
; 78(4): 567-577, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32936950
2.
Butyrophilin Btn2a2 inhibits TCR activation and phosphatidylinositol 3-kinase/Akt pathway signaling and induces Foxp3 expression in T lymphocytes.
J Immunol
; 190(10): 5030-6, 2013 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23589618
3.
BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation.
J Immunol
; 184(7): 3514-25, 2010 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20208008
4.
Sensitization of neuroblastoma cells for TRAIL-induced apoptosis by NF-kappaB inhibition.
Int J Cancer
; 124(6): 1301-11, 2009 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19065652
5.
Multicentric analytical comparability study of programmed death-ligand 1 expression on tumor-infiltrating immune cells and tumor cells in urothelial bladder cancer using four clinically developed immunohistochemistry assays.
Virchows Arch
; 475(5): 599-608, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31267201
6.
Detection of weak receptor-ligand interactions using IgM and J-chain-based fusion proteins.
Eur J Immunol
; 42(5): 1354-6, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22539303
7.
Development and use of IgM/J-chain fusion proteins for characterization of immunoglobulin superfamily ligand-receptor interactions.
Curr Protoc Protein Sci
; 75: 19.24.1-19.24.11, 2014 Feb 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-24510674
Resultados
1 -
7
de 7
1
Próxima >
>>